Abbott Laboratories
ABT
ISIN null / Valor 903037
Abbott Laboratories
UMushroom community rating:
About company
Abbott Laboratories is a global healthcare company with a history spanning over 135 years, dedicated to improving lives through a wide range of healthcare products and technologies. With operations in more than 160 countries and a workforce of approximately 114,000 employees, Abbott focuses on major areas including cardiovascular care, diabetes care, diagnostics, neuromodulation, nutrition, and branded generic medicines. The company is known for its innovative solutions in managing health conditions, offering products like glucose monitoring systems that eliminate the need for painful fingersticks and technologies aimed at treating chronic pain and movement disorders. Abbott's commitment to healthcare innovation and its broad portfolio of products cater to the needs of consumers and healthcare professionals worldwide, aiming to make a lasting impact on global health.
Summarized from source with an LLMView SourceSector: HealthcareLatest Results (20.10.2025):
Abbott Laboratories reported its financial results for the third quarter of 2025, demonstrating a reported sales growth of 6.9%, an organic growth of 5.5%, and a 7.5% increase excluding COVID-19 testing-related sales. The company achieved a GAAP diluted EPS of $0.94 and an adjusted diluted EPS of $1.30, alongside an improved operating margin.
Sales Growth
Abbott Laboratories saw a 6.9% rise in reported sales for Q3 2025, with organic sales growing by 5.5% and 7.5% when excluding COVID-19 testing-related sales.
Earnings Per Share
The third-quarter GAAP diluted EPS was $0.94, while the adjusted diluted EPS reached $1.30, reflecting strong profitability.
Operating Margin
Abbott Laboratories reported an operating margin of 18.1% of sales and an adjusted operating margin of 23.0%, marking a 40 basis point increase.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
222767 M
Market cap (USD)
9,400,951
Daily traded volume (Shares)
114.3 / 112.52
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
